FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)

FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) is sponsored by FDA. This program provides federal financial assistance for high-quality conferences and scientific meetings that research and investigate topics aligned with the FDA's mission and public health.

Opportunity Listing - FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) Agency: Food and Drug Administration Assistance Listings: 93. 103 -- Food and Drug Administration Research Last Updated: May 13, 2026 View version history on Grants.

gov The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission. The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health.

A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission. Permission to submit a conference grant application does not assure funding or funding at the level requested.

FDA will not issue a conference grant award unless it can be issued before the conference start date.

Independent school districts Other Native American tribal organizations Nonprofits non-higher education without 501(c)(3) Nonprofits non-higher education with 501(c)(3) For-profit organizations other than small businesses Federally recognized Native American tribal governments City or township governments Foreign Institutions are not eligible to apply Grantor contact information Grants Management Specialist danielle. head@fda. hhs.

gov danielle. head@fda. hhs.

gov File name Description Last updated PAR-23-072__FDA_Support_for_Conferences...

pdf Full Announcement of PAR-23-072 Dec 13, 2022 04:53 PM UTC Link to additional information Full Announcement of PAR-23-072 Archived: January 31, 2026 Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.